Liquidia Co. (NASDAQ:LQDA) Receives Average Rating of “Moderate Buy” from Brokerages

Liquidia Co. (NASDAQ:LQDA) has been assigned an average recommendation of “Moderate Buy” from the six analysts that are covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $21.00.

A number of equities research analysts have recently issued reports on LQDA shares. Needham & Company LLC reiterated a “buy” rating and set a $28.00 price target on shares of Liquidia in a research report on Monday, June 3rd. Oppenheimer initiated coverage on Liquidia in a research report on Tuesday, June 25th. They set a “market perform” rating on the stock. Finally, HC Wainwright reaffirmed a “buy” rating and set a $32.00 price target on shares of Liquidia in a research note on Wednesday, May 15th.

Insider Transactions at Liquidia

In related news, CFO Michael Kaseta sold 3,136 shares of Liquidia stock in a transaction dated Friday, April 12th. The stock was sold at an average price of $14.58, for a total transaction of $45,722.88. Following the completion of the sale, the chief financial officer now owns 315,045 shares in the company, valued at approximately $4,593,356.10. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other Liquidia news, CFO Michael Kaseta sold 3,136 shares of the firm’s stock in a transaction dated Friday, April 12th. The shares were sold at an average price of $14.58, for a total transaction of $45,722.88. Following the sale, the chief financial officer now directly owns 315,045 shares of the company’s stock, valued at approximately $4,593,356.10. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Roger Jeffs sold 8,360 shares of Liquidia stock in a transaction dated Friday, April 12th. The stock was sold at an average price of $14.58, for a total transaction of $121,888.80. Following the sale, the chief executive officer now owns 826,985 shares of the company’s stock, valued at $12,057,441.30. The disclosure for this sale can be found here. Insiders sold a total of 18,653 shares of company stock valued at $270,409 over the last three months. 31.60% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the business. American International Group Inc. increased its stake in Liquidia by 5.2% in the first quarter. American International Group Inc. now owns 24,806 shares of the company’s stock valued at $366,000 after purchasing an additional 1,215 shares during the last quarter. Bleakley Financial Group LLC lifted its holdings in shares of Liquidia by 6.6% during the 1st quarter. Bleakley Financial Group LLC now owns 33,250 shares of the company’s stock worth $490,000 after acquiring an additional 2,057 shares during the period. Fortitude Family Office LLC acquired a new stake in shares of Liquidia in the fourth quarter worth approximately $26,000. SG Americas Securities LLC boosted its position in shares of Liquidia by 17.4% in the fourth quarter. SG Americas Securities LLC now owns 15,540 shares of the company’s stock worth $187,000 after acquiring an additional 2,298 shares during the last quarter. Finally, Corton Capital Inc. grew its holdings in Liquidia by 14.2% in the third quarter. Corton Capital Inc. now owns 23,440 shares of the company’s stock valued at $149,000 after purchasing an additional 2,921 shares during the period. Hedge funds and other institutional investors own 64.54% of the company’s stock.

Liquidia Price Performance

Liquidia stock opened at $12.04 on Tuesday. The stock’s 50 day moving average price is $12.82 and its 200 day moving average price is $13.32. Liquidia has a 1-year low of $5.71 and a 1-year high of $16.99. The company has a market cap of $919.21 million, a PE ratio of -7.72 and a beta of 0.25.

Liquidia (NASDAQ:LQDA) last posted its quarterly earnings results on Monday, May 13th. The company reported ($0.54) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.32) by ($0.22). Liquidia had a negative return on equity of 177.83% and a negative net margin of 674.42%. The company had revenue of $2.97 million for the quarter, compared to analyst estimates of $4.31 million. On average, equities research analysts anticipate that Liquidia will post -1.32 EPS for the current fiscal year.

Liquidia Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).